BluePrint Orphan: Strategic Advisory Services
BluePrint Orphan maintains active relationships with hundreds of companies with interest in orphan products (preclinical through phase III). As the Orphan industry's preeminent leader in licensing strategy and opportunity identification & assessment, we will likely succeed in locating a partner interested in acquiring or licensing your IP.
Contact us add your asset(s) to our private, client-facing listing and learn more about our services:
Top 3 reasons clients choose BluePrint Orphan vs. other investment banks or consultancies:
- We are experts in Orphan. (with a history of having launched some of the world's most prominent brands)
- Senior-heavy team with vast, global experience across therapeutic areas.
- Modest, success-based fees. We succeed when our clients do.